In a short interview on RAC1 Radio, Lluís Ribas, ICREA researcher at IRB Barcelona, talks about the disturbing fall in the number of antibiotics available to treat infections—which has come about from “a vicious cycle between big pharma and regulatory agencies”. This decrease takes on great relevance given the increasing resistance of bacteria to antibiotics.
“Public-funded research can provide the solution, by allowing the constant discovery of new antibiotics to replace those to which bacteria have become resistant,” explains Lluís Ribas.
Eva Novoa was one of the first students to complete a PhD in as part of the ”la Caixa”/IRB Barcelona International PhD Programme in Biomedicine. She was a PhD student at IRB Barcelona between 2008 and 2012. Six months ago, she moved to Sydney, Australia to join the Garvan Institute of Medical Research as a Senior Research Officer. She just received the Young Research Award from the Catalan Society for Biology.
In an extensive interview in the Art and Science Channel Excodra, Lluís Ribas de Pouplana, ICREA researcher at IRB Barcelona, talks about many topics related to life, evolution, the genetic code and diseases.
In response to a question about how he thinks our species will evolve, Ribas says, "the genes that will exert greatest influence on our evolution are those involved in heat regulation because the inevitable phenomenon of global warming is on its way". The interview ends with advice for young researchers when they face failed experiments: "Many people can’t even get to do this experiment; what we do is great, we explore, we search for things and sometimes we find them."...
Publico.es echoes a finding linked to the Rosetta space mission. The journalistic article describes the discovery of organic molecules on a comet and provides clues as to about how life may have arisen on Earth—one of the great enigmas of science. The journalist also mentions the discovery made by ICREA researcher at IRB Barcelona, Lluís Ribas de Pouplana, published in Science Advances, about the fundamental limit reached by the genetic code—the...
"In love with the genetic code", the new video in the series Meet Our Scientists, presents the research performed by Lluís Ribas on the genetic code and protein synthesis, both of which are essential for life.
Ribas highlights the impact of the evolution of the enzyme ADAT, described in the journal Cell in 2012. The appearance of ADAT was decisive for the separation of species into the three domains of life, and it could be of biomedical and biotech relevance.
Broad international and national coverage of the study on the evolution of the genetic code published in Science Advances by Lluís Ribas, ICREA professor at IRB Barcelona. Sarah Emerson, editor of Motherboard, writes an article aimed at the general public on what caused the genetic code to stop evolving 3000 million years ago.
Read the article in Motherboard (USA)
Read the Article in Daily Mail (UK):...
A study performed at IRB Barcelona offers an explanation as to why the genetic code, the dictionary used by organisms to translate genes into protein, stopped growing 3,000 million years ago.
The reason is attributed to the structure of transfer RNAs—the key molecules in the translation of genes into proteins.
The genetic code is limited to 20 amino acids—the building blocks of proteins—the maximum number that prevents systematic mutations, which are fatal for life.
The discovery could have applications in synthetic biology.
Extensive report in El Mundo on the 10th anniversary of IRB Barcelona, including an interview with the director of the centre, Joan J. Guinovart. Sections devoted to highlighting the research performed by Ángel R. Nebreda and Lluís Ribas de Pouplana.
Coinciding with the announcement by the WHO about a 50% decrease in number of cases of malaria, TV3 also explains IRB’s discovery of compounds that eliminate malaria in mice. ICREA researcher Lluís Ribas de Pouplana further explains that the treated mice developed an immune memory that protects against future infections.
Cadena Ser radio, like other national and international media, has reported on the results obtained by Lluís Ribas’s team on new borrelidin-based compounds to combat the malaria-causing parasite Plasmodium. This study, published in the PNAS journal, was performed in mice, and showed that the compounds were 100% effective. In addition, the mice developed immune memory against future infections, a feature not achieved previously in an anti-malarial drug.
Listen to the news on Cadena Ser (in Spanish, minute 18)